Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Yuki Homma
Koichi Taniguchi
Takashi Murakami
Kazuya Nakagawa
Masatoshi Nakazawa
Ryusei Matsuyama
Ryutaro Mori
Kazuhisa Takeda
Michio Ueda
Yasushi Ichikawa
Kuniya Tanaka
Itaru Endo
机构：
[1] Yokohama City University Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Yokohama City University School of Medicine,Department of Experimental Animal Medicine
来源：
Annals of Surgical Oncology | 2014年 / 21卷
关键词：
Overall Survival; Pancreatic Cancer; Major Histocompatibility Complex Class; Pancreatic Ductal Adenocarcinoma; Antitumor Immune Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：670 / 676
页数：6
相关论文
共 50 条
  • [1] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Homma, Yuki
    Taniguchi, Koichi
    Murakami, Takashi
    Nakagawa, Kazuya
    Nakazawa, Masatoshi
    Matsuyama, Ryusei
    Mori, Ryutaro
    Takeda, Kazuhisa
    Ueda, Michio
    Ichikawa, Yasushi
    Tanaka, Kuniya
    Endo, Itaru
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 670 - 676
  • [2] Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma
    Suto, Hironobu
    Oshima, Minoru
    Ando, Yasuhisa
    Matsukawa, Hiroyuki
    Takahashi, Shigeo
    Shibata, Toru
    Kamada, Hideki
    Kobara, Hideki
    Masaki, Tsutomu
    Kumamoto, Kensuke
    Suzuki, Yasuyuki
    Okano, Keiichi
    [J]. HPB, 2023, 25 (01) : 136 - 145
  • [3] Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy
    Shohei Takaichi
    Yoshito Tomimaru
    Shogo Kobayashi
    Keisuke Toya
    Kazuki Sasaki
    Yoshifumi Iwagami
    Daisaku Yamada
    Takehiro Noda
    Hidenori Takahashi
    Tadafumi Asaoka
    Masahiro Tanemura
    Yuichiro Doki
    Hidetoshi Eguchi
    [J]. Annals of Surgical Oncology, 2023, 30 : 2458 - 2468
  • [4] Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma
    Takaori, Ayaka
    Hashimoto, Daisuke
    Ikeura, Tsukasa
    Ito, Takashi
    Nakamaru, Koh
    Masuda, Masataka
    Nakayama, Shinji
    Yamaki, So
    Yamamoto, Tomohisa
    Fujimoto, Kosuke
    Matsuo, Yoshiyuki
    Akagawa, Shohei
    Ishida, Mitsuaki
    Yamaguchi, Kiyoshi
    Imoto, Seiya
    Hirota, Kiichi
    Uematsu, Satoshi
    Satoi, Sohei
    Sekimoto, Mitsugu
    Naganuma, Makoto
    [J]. PANCREATOLOGY, 2023, 23 (04) : 367 - 376
  • [5] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kaufmann, Benedikt
    Hartmann, Daniel
    D'Haese, Jan G.
    Stupakov, Pavel
    Radenkovic, Dejan
    Gloor, Beat
    Friess, Helmut
    [J]. DIGESTIVE SURGERY, 2019, 36 (06) : 455 - 461
  • [6] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1193 - 1198
  • [7] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    R. Álvarez
    I. Alés
    R. Díaz
    B. G. de Paredes
    M. Hidalgo
    [J]. Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
  • [8] Local Immunological Effect of Neoadjuvant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Cancer
    Murakami, T.
    Mori, R.
    Matsuyama, R.
    Homma, Y.
    Nakazawa, M.
    Tanaka, Y.
    Miyake, K.
    Sawada, Y.
    Oota, Y.
    Hiroshima, Y.
    Kumamoto, T.
    Ueda, M.
    Takeda, K.
    Ichikawa, Y.
    Tanaka, K.
    Endo, I.
    [J]. PANCREAS, 2014, 43 (08) : 1394 - 1394
  • [9] ASO Visual Abstract: Change Impact of Body Composition during Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy
    Takaichi, Shohei
    Tomimaru, Yoshito
    Kobayashi, Shogo
    Toya, Keisuke
    Sasaki, Kazuki
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Noda, Takehiro
    Takahashi, Hidenori
    Asaoka, Tadafumi
    Tanemura, Masahiro
    Doki, Yuichiro
    Eguchi, Hidetoshi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2471 - 2472
  • [10] Neoadjuvant therapy duration and outcome of patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC).
    Shahda, Safi
    Perkins, Susan
    Cramer, Harvey M.
    House, Michael Garrett
    Nakeeb, Attila
    Zyromski, Nicholas J.
    Ceppa, Eugene P.
    Sehdev, Amikar
    Akisik, Fatih
    Lin, Jingmei
    Schmidt, Christian
    Ellsworth, Susannah G.
    O'Neil, Nina
    Link, Kristen
    O'Neil, Bert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345